We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ALTO/MARKETING LIMITED

Industry News

Image: The Atellica Solution immunoassay and clinical chemistry analyzers (Photo courtesy of Siemens Healthineers).

Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics

Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country. More...
12 Nov 2018
Image: Roche has launched Roche Healthcare Consulting to improve the performance of healthcare groups (Photo courtesy of Roche).

Roche Launches Roche Healthcare Consulting

Roche (Basel, Switzerland) has launched Roche Healthcare Consulting, a specialized consulting service that aims to help leaders in laboratories, hospitals and other healthcare groups optimize their operational, clinical and financial performance. More...
18 Oct 2018
Image: Snibe showcased its latest range of chemiluminescent immunoassay analyzers at MEDLAB Europe 2018 (Photo courtesy of Snibe).

Snibe Diagnostic Displays Analyzers at MEDLAB Europe 2018

Shenzhen New Industries Biomedical Engineering Co., Ltd. showcased its latest range of chemiluminescent immunoassay analyzers at MEDLAB Europe 2018 held in Barcelona, Spain, from October 2-4, 2018. More...
04 Oct 2018
Image: MEDLAB Europe 2018 covered a range of topics, including POCT, immunology, lab management anatomic pathology, clinical microbiology and hematology (Photo courtesy of iStock).

MEDLAB Europe 2018 Presents Latest Technologies and Developments

MEDLAB Europe 2018, which took place in Barcelona, Spain, from October 2-4, 2018, featured over 150 exhibitors showcasing the latest cutting-edge technologies and recent developments in the medical laboratory industry. The second edition of the show welcomed more than 2,600 international visitors and delegates, offering international manufacturers a chance to network with over 1,000 medical dealers and distributors from Spain, Italy, France, Germany, Portugal and other countries. More...
04 Oct 2018
Image: The global medical gas analyzers market is being driven by upsurge in the adoption of medical gas analyzers, stringent regulations for medical gas systems, and increase in demand for advanced medical gas analyzing systems (Photo courtesy of Getty Images).

Global Medical Gas Analyzers Market to Reach USD 325 Million by 2025

The global medical gas analyzers market was valued at USD 235 million in 2017 and is expected to grow at a CAGR of 4.1% from 2018 to 2025 to reach USD 325 million by 2025, driven by an upsurge in the adoption of medical gas analyzers, stringent regulations for medical gas systems, and increase in demand for advanced medical gas analyzing systems. An increase in the number of medical gas therapies due to a surge in the number of patients treated in intensive care units (ICUs), neonatal intensive care units (NICUs), and emergency departments, as well as a surge in number of hospitals & surgery centers will further support the market growth. More...
01 Oct 2018
Image: The global hemostasis/coagulation analyzers market is expected to grow to USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders (Photo courtesy of Analyticon Biotechnologies.

Global Hemostasis/Coagulation Analyzers Market to Reach USD 9.5 Billion by 2026

The global hemostasis/coagulation analyzers market was valued at USD 3.65 billion in 2017 and is expected to grow at a CAGR of 9.9% over the period 2018 to 2026 to reach USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders. Technological innovations and miniaturization has led to the commercialization of several novel devices that have quick turnaround time and can also be used in point of care (POC) settings. Additionally, growing awareness and demand for technologically advanced medical treatments, government support and increasing adoption of laboratory automation are driving the demand for novel coagulation analyzers. More...
01 Oct 2018
Image: Handheld hematology devices are expected to contribute to the growth of the global POC hematology diagnostics market (Photo courtesy of Philips Healthcare).

Increasing Conditions and Diseases Drive Global POC Hematology Diagnostics Market

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology conditions and infectious diseases such as sickle cell disease, thalassemia, and polycythemia. Additionally, the increased adoption of next-generation hematology diagnostic products such as handheld hematology devices and non-invasive hematology testing will further contribute to the growth of the global POC hematology diagnostics market. More...
20 Sep 2018


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2018 Globetech Media. All rights reserved.